Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer

The Uromigos - A podcast by The Uromigos

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Mike Atkins describes the results of this study which helps shed light on the role of ipilimumab and nivolumab in this disease.